JP2018513117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513117A5 JP2018513117A5 JP2017546870A JP2017546870A JP2018513117A5 JP 2018513117 A5 JP2018513117 A5 JP 2018513117A5 JP 2017546870 A JP2017546870 A JP 2017546870A JP 2017546870 A JP2017546870 A JP 2017546870A JP 2018513117 A5 JP2018513117 A5 JP 2018513117A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- formulated
- dexamethasone
- corneal
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ705727 | 2015-03-05 | ||
| NZ70572715 | 2015-03-05 | ||
| PCT/NZ2016/050033 WO2016140581A1 (en) | 2015-03-05 | 2016-03-04 | Ophthalmic compositions and methods of use therefor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021011148A Division JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018513117A JP2018513117A (ja) | 2018-05-24 |
| JP2018513117A5 true JP2018513117A5 (enExample) | 2019-04-11 |
Family
ID=56848288
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546870A Pending JP2018513117A (ja) | 2015-03-05 | 2016-03-04 | 眼科用組成物およびその使用方法 |
| JP2021011148A Pending JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
| JP2023030945A Active JP7641650B2 (ja) | 2015-03-05 | 2023-03-01 | 眼科用組成物およびその使用方法 |
| JP2024218517A Pending JP2025032318A (ja) | 2015-03-05 | 2024-12-13 | 眼科用組成物およびその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021011148A Pending JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
| JP2023030945A Active JP7641650B2 (ja) | 2015-03-05 | 2023-03-01 | 眼科用組成物およびその使用方法 |
| JP2024218517A Pending JP2025032318A (ja) | 2015-03-05 | 2024-12-13 | 眼科用組成物およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10842850B2 (enExample) |
| EP (1) | EP3265096B9 (enExample) |
| JP (4) | JP2018513117A (enExample) |
| KR (1) | KR102450674B1 (enExample) |
| CN (1) | CN107530360B (enExample) |
| AU (1) | AU2016226699B2 (enExample) |
| ES (1) | ES2952700T3 (enExample) |
| MY (1) | MY186271A (enExample) |
| SG (1) | SG11201708114SA (enExample) |
| TW (1) | TWI747816B (enExample) |
| WO (1) | WO2016140581A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| EP4420725A3 (en) | 2012-03-29 | 2025-04-16 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
| US9566301B2 (en) | 2012-03-29 | 2017-02-14 | Cxl Ophthalmics, Llc | Compositions and methods for treating or preventing diseases associated with oxidative stress |
| TWI747816B (zh) * | 2015-03-05 | 2021-12-01 | 紐西蘭商奧克蘭聯合服務有限公司 | 眼用組合物用於製備藥物的用途 |
| WO2017015471A1 (en) | 2015-07-21 | 2017-01-26 | Avedro, Inc. | Systems and methods for treaments of an eye with a photosensitizer |
| CN110092816B (zh) * | 2018-01-29 | 2023-08-01 | 上海市第一人民医院 | 预防和治疗纤维化的小分子多肽及其应用 |
| US20210060017A1 (en) * | 2018-02-27 | 2021-03-04 | Shilpa Medicare Ltd | Methotrexate ophthalmic solution |
| CN108728418A (zh) * | 2018-06-19 | 2018-11-02 | 新乡医学院 | 一种鸡胚中枢神经系统单个神经元动态研究模型的制备方法及应用 |
| US11672860B2 (en) * | 2018-11-02 | 2023-06-13 | Senseonics, Incorporated | Drug eluting matrix on analyte indicator |
| GB201820021D0 (en) * | 2018-12-07 | 2019-01-23 | Univ Birmingham | Ocular hydrogel compositions |
| JP2022125941A (ja) * | 2021-02-17 | 2022-08-29 | 株式会社ティ・エム・ディ | コンタクトレンズ |
| WO2024206871A1 (en) * | 2023-03-30 | 2024-10-03 | Cetel Scientific Llc | Amniotic and chorionic collagen for ocular surface healing |
| KR20250092172A (ko) | 2022-09-01 | 2025-06-23 | 옵티파이 테라퓨틱스 아게 | 안과용 조성물 |
| US20240119865A1 (en) * | 2022-10-07 | 2024-04-11 | Life Model Designs LLC | Synthetic blood clot |
| CN121490062B (zh) * | 2026-01-12 | 2026-05-15 | 上饶爱尔眼科医院有限公司 | 含地塞米松的组合物及其在制备治疗视网膜病变的药物中的应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3786812A (en) * | 1972-03-10 | 1974-01-22 | C Neefe | Contact lens for olar drug delivery |
| US4177268A (en) | 1973-05-30 | 1979-12-04 | Jouveinal S.A. | Method of alleviating inflammation by administration of dexamethasone derivatives |
| US5124392A (en) * | 1988-10-03 | 1992-06-23 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
| JPH06505965A (ja) * | 1990-11-16 | 1994-07-07 | セルトリックス ファーマシューティカルズ，インコーポレイテッド | β型トランスフォーミング成長因子 |
| US5411940A (en) * | 1993-09-29 | 1995-05-02 | Alcon Laboratories, Inc. | Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
| NZ566132A (en) | 2003-02-13 | 2009-09-25 | Anthrogenesis Corp | Use of umbilical cord blood to treat inflammation, ParkinsonÆs disease or diabetes |
| MXPA03011987A (es) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
| US20090232777A1 (en) * | 2006-03-01 | 2009-09-17 | Evy Lundgren-Akerlund | Expansion and Differentiation of Mesenchymal Stem Cells |
| GB0604938D0 (en) | 2006-03-11 | 2006-04-19 | Renovo Ltd | Proteins, nucleic acids and medicaments |
| US7767217B2 (en) | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| US8110655B2 (en) | 2006-11-13 | 2012-02-07 | Auxagen, Inc. | Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor |
| RU2542471C2 (ru) | 2006-11-15 | 2015-02-20 | Коуда Терапьютикс, Инк. | Улучшенные способы и композиции для заживления ран |
| EP2229174A1 (en) | 2007-12-04 | 2010-09-22 | Novagali Pharma S.A. | Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders |
| US7795316B1 (en) | 2007-12-19 | 2010-09-14 | Alcon Research, Ltd. | Topical ophthalmic compositions containing tobramycin and dexamethasone |
| CA2716390C (en) | 2008-02-25 | 2016-08-23 | Eyegate Pharma S.A.S. | Enhanced delivery of a therapeutic to ocular tissues through iontophoresis |
| EP2962682B1 (en) * | 2008-12-11 | 2018-03-28 | Massachusetts Institute Of Technology | Method of making a contact lens drug delivery device |
| US10201548B2 (en) | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| WO2012088044A2 (en) * | 2010-12-20 | 2012-06-28 | James Mcmillan | Compositions and methods for improving ocular surface health, corneal clarity, optical function and maintaining visual acuity |
| US20130165419A1 (en) * | 2011-12-21 | 2013-06-27 | Insite Vision Incorporated | Combination anti-inflammatory ophthalmic compositions |
| KR101518370B1 (ko) | 2013-06-25 | 2015-05-07 | 가톨릭대학교 산학협력단 | Il-10 생성 조절 t세포로의 분화 유도용 조성물 |
| CN104548210A (zh) | 2014-12-13 | 2015-04-29 | 浙江大学 | 含地塞米松转化生长因子的可控缓释plga微球及制备 |
| TWI747816B (zh) | 2015-03-05 | 2021-12-01 | 紐西蘭商奧克蘭聯合服務有限公司 | 眼用組合物用於製備藥物的用途 |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
-
2016
- 2016-03-04 TW TW105106605A patent/TWI747816B/zh active
- 2016-03-04 MY MYPI2017703238A patent/MY186271A/en unknown
- 2016-03-04 SG SG11201708114SA patent/SG11201708114SA/en unknown
- 2016-03-04 US US15/555,909 patent/US10842850B2/en active Active
- 2016-03-04 JP JP2017546870A patent/JP2018513117A/ja active Pending
- 2016-03-04 ES ES16759200T patent/ES2952700T3/es active Active
- 2016-03-04 EP EP16759200.5A patent/EP3265096B9/en active Active
- 2016-03-04 AU AU2016226699A patent/AU2016226699B2/en active Active
- 2016-03-04 CN CN201680026065.0A patent/CN107530360B/zh active Active
- 2016-03-04 KR KR1020177028161A patent/KR102450674B1/ko active Active
- 2016-03-04 WO PCT/NZ2016/050033 patent/WO2016140581A1/en not_active Ceased
-
2020
- 2020-10-23 US US17/078,949 patent/US11938168B2/en active Active
-
2021
- 2021-01-27 JP JP2021011148A patent/JP2021091688A/ja active Pending
-
2023
- 2023-03-01 JP JP2023030945A patent/JP7641650B2/ja active Active
-
2024
- 2024-12-13 JP JP2024218517A patent/JP2025032318A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kim et al. | Laser in situ keratomileusis versus laser-assisted subepithelial keratectomy for the correction of high myopia | |
| Miranda et al. | Ferrara intrastromal corneal ring segments for severe keratoconus | |
| Lee et al. | Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser | |
| Zhang et al. | A review of collagen cross‐linking in cornea and sclera | |
| Paysse et al. | Pediatric refractive surgery: corneal and intraocular techniques and beyond | |
| Althomali | Posterior chamber toric phakic IOL implantation for the management of pediatric anisometropic amblyopia | |
| Kramer et al. | Scleral lenses in the treatment of post-LASIK ectasia and superficial neovascularization of intrastromal corneal ring segments | |
| Manns et al. | Use of corneal cross-linking beyond keratoconus: a systemic literature review | |
| El-Agha et al. | Comparison of photorefractive keratectomy and laser in situ keratomileusis for the treatment of compound hyperopic astigmatism | |
| Lane et al. | Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap | |
| Eissa et al. | ICL versus SMILE in management of anisometropic myopic amblyopia in children | |
| de Benito-Llopis et al. | Comparison between LASEK and LASIK for the correction of low myopia | |
| Kim et al. | Full-thickness astigmatic keratotomy combined with small-incision lenticule extraction to treat high-level and mixed astigmatism | |
| Stahl | Pediatric refractive surgery | |
| Durrie et al. | Secondary intraocular lens implantation vs epikeratophakia for the treatment of aphakia | |
| Chen et al. | Management of complex epithelial ingrowth after laser in situ keratomileusis using fibrin tissue glue | |
| Hafez | Comparison of epithelium-off and transepithelial corneal collagen cross-linking for treatment of keratoconus | |
| Magli et al. | Photorefractive keratectomy for myopic anisometropia: a retrospective study on 18 children | |
| Frank et al. | Cosmetic Iris Implants—the Pressure of Being Beautiful | |
| Jankov et al. | Lenticular intrastromal keratoplasty for keratoconus | |
| RU2816066C1 (ru) | Способ лечения повреждений роговичного лоскута микрокератомом в процессе кераторефракционной операции LASIK или Femtolasik | |
| Sánchez-González et al. | Permavision intracorneal inlay after sixteen years. Regression of initial refractive hyperopia | |
| Artemiev | Effect of postoperative subconjunctival corticosteroid injections in a multimodal approach for the treatment of severe symblepharon | |
| Soori et al. | Refractive outcomes of small incision lenticule extraction with accelerated cross-linking (ReLEx SMILE Xtra) in patients with thin cornea | |
| Shaher et al. | Comparison of clinical results between flap-on and flap-off techniques of epithelial-laser in situ keratomileusis in correction of low to moderate myopia in eyes with thin corneas |